NUTEX Investments (BUD:NUTEX) PE Ratio: 3.94 (As of Jul. 03, 2026) — 73% Below Median


BUD:NUTEX NUTEX Investments PLC BUD:NUTEX
50 GF Score
Price Ft13.40
GF Value Ft13.80
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is NUTEX Investments PE Ratio?

NUTEX Investments BUD:NUTEX -0.37% 50 PE Ratio is 3.94 as of Jul. 03, 2026, which is 73% below its 10-year median of 14.64. GuruFocus rates BUD:NUTEX with a GF Score™ of 50/100 and a GF Value™ of Ft13.80 (Fairly Valued). The stock has 3 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-03), NUTEX Investments's share price is Ft13.40. NUTEX Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was Ft3.40. Therefore, NUTEX Investments's PE Ratio for today is 3.94.

Good Sign:

NUTEX Investments PLC stock PE Ratio (=3.96) is close to 5-year low of 3.81.

During the past 13 years, NUTEX Investments's highest PE Ratio was 188.20. The lowest was 0.81. And the median was 14.64.

NUTEX Investments's EPS (Diluted) for the six months ended in Dec. 2025 was Ft2.51. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was Ft3.40.

As of today (2026-07-03), NUTEX Investments's share price is Ft13.40. NUTEX Investments's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was Ft1.64. Therefore, NUTEX Investments's PE Ratio without NRI ratio for today is 8.19.

During the past 13 years, NUTEX Investments's highest PE Ratio without NRI was 188.20. The lowest was 0.81. And the median was 21.29.

NUTEX Investments's EPS without NRI for the six months ended in Dec. 2025 was Ft2.51. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was Ft1.64.

During the past 12 months, NUTEX Investments's average EPS without NRI Growth Rate was 33.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 88.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 86.10% per year.

During the past 13 years, NUTEX Investments's highest 3-Year average EPS without NRI Growth Rate was 194.00% per year. The lowest was -59.10% per year. And the median was 46.60% per year.

NUTEX Investments's EPS (Basic) for the six months ended in Dec. 2025 was Ft2.91. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was Ft3.80.

Back to Basics: PE Ratio


NUTEX Investments  (BUD:NUTEX) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


NUTEX Investments PE Ratio Related Terms


NUTEX Investments PE Ratio Historical Data

* Premium members only.

The historical data trend for NUTEX Investments's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NUTEX Investments PE Ratio Chart

NUTEX Investments Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 149.00 16.18 12.57 8.58 4.12

NUTEX Investments Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.57 At Loss 8.58 At Loss 4.12

BUD:NUTEX vs ZTS, UTHR, VTRS: PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NUTEX Investments PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's PE Ratio distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's PE Ratio falls into.


BUD:NUTEX
50GF Score
NUTEX Investments PLC BUD:NUTEX
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NUTEX Investments PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

NUTEX Investments's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=13.40/3.400
=3.94

NUTEX Investments's Share Price of today is Ft13.40.
For company reported semi-annually, NUTEX Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was Ft3.40.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 3.94 mean?
NUTEX Investments (BUD:NUTEX) has a PE Ratio of 3.94 as of Jul. 03, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on NUTEX Investments and its competitors. This is 73% below median its historical median of 14.64. Over the past decade, NUTEX Investments' PE Ratio has ranged from 0.81 to 188.20.
Is NUTEX Investments' PE Ratio too high?
NUTEX Investments' current PE Ratio of 3.94 is 73% below median its 10-year median of 14.64. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 188.20. Overall, NUTEX Investments has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NUTEX Investments' PE Ratio compare to ZTS and UTHR?
NUTEX Investments' PE Ratio of 3.94 can be compared against companies in the Drug Manufacturers industry. Historically, NUTEX Investments' own PE Ratio has ranged from 0.81 to 188.20 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Drug Manufacturers company?
A good PE Ratio depends on the Drug Manufacturers industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on NUTEX Investments and its competitors. NUTEX Investments's current PE Ratio is 3.94, which is 73% below median its own 10-year median of 14.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NUTEX Investments stock overvalued right now?
Based on GuruFocus' analysis, NUTEX Investments (BUD:NUTEX) is currently considered Fairly Valued. The stock's GF Value™ is Ft13.80, compared to a current price of Ft13.40 — trading 2.9% below its estimated fair value. The current PE Ratio is 3.94, which is 73% below median its 10-year median of 14.64. NUTEX Investments' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For NUTEX Investments (BUD:NUTEX), the current PE Ratio is 3.94 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NUTEX Investments (BUD:NUTEX) Overvalued in 2026?

Based on GuruFocus' analysis, NUTEX Investments stock appears to be undervalued. The current stock price of Ft13.40 is trading 2.9% below its estimated GF Value™ of Ft13.80. GuruFocus considers NUTEX Investments to be Fairly Valued.

Key valuation signals for BUD:NUTEX:

  • PE Ratio: 3.94 (73% below median its 10-year median of 14.64)
  • GF Value™: Ft13.80 vs. price of Ft13.40 (2.9% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the BUD:NUTEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NUTEX Investments Business Description

Address Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.
50GF Score

Get the complete analysis for BUD:NUTEX

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft13.40
Price
Ft13.80
GF Value